Stimulating ERK/PI3K/NFκB signaling pathways upon activation of mGluR2/3 restores OGD-induced impairment in glutamate clearance in astrocytes
- PMID: 24206109
- DOI: 10.1111/ejn.12383
Stimulating ERK/PI3K/NFκB signaling pathways upon activation of mGluR2/3 restores OGD-induced impairment in glutamate clearance in astrocytes
Abstract
We used the oxygen and glucose deprivation (OGD) method in cultured astrocytes as an in vitro ischemic model. We investigated whether activation of group-II metabotropic glutamate receptors (mGluR2/3) can reverse OGD-induced impairment in astrocytic glutamate/aspartate transporter (GLAST) expression and elucidated the signaling pathways involving the GLAST expression. Cultured astrocytes exposed to OGD for 6 h resulted in significant reductions in the GLAST expression and extracellular glutamate clearance. These reductions were effectively restored by mGluR2/3 activation with mGluR2/3 agonists, LY379268 or DCG-IV, after the 6 h OGD insult. These mGluR2/3-mediated restorative effects were inhibited by selective mGluR2/3 antagonists LY341459 or EGLU. The mGluR2/3 activation also induced activations of signaling pathways including extracellular signal-regulated kinase (ERK), phosphatidylinositol 3-kinase (PI3K) and nuclear transcription factor-κB (NFκB). These activations were prevented by blocking mGluR2/3 with LY341459, an mGluR2/3 antagonist. Furthermore, blocking ERK, PI3K and NFκB signaling pathways with U0126, LY294002 and pyrrolidine dithiocarbamate, respectively, significantly inhibited the mGluR2/3-mediated restorative effects. These results suggest that application of mGluR2/3 agonists after OGD insult can effectively reverse the OGD-reduced expression of GLAST proteins and restore clearance of extracellular glutamate by serially activating ERK/PI3K/NFκB signaling pathways in cultured astrocytes.
Keywords: astrocyte GLAST; extracellular signal-regulated kinase; mGluR2/3 agonists; nuclear transcription factor-κΒ; oxygen and glucose deprivation; phosphatidylinositol 3-kinase.
© 2013 Federation of European Neuroscience Societies and John Wiley & Sons Ltd.
Similar articles
-
Molecular signalling mediating the protective effect of A1 adenosine and mGlu3 metabotropic glutamate receptor activation against apoptosis by oxygen/glucose deprivation in cultured astrocytes.Mol Pharmacol. 2007 May;71(5):1369-80. doi: 10.1124/mol.106.031617. Epub 2007 Feb 9. Mol Pharmacol. 2007. PMID: 17293559
-
High extracellular glutamate modulates expression of glutamate transporters and glutamine synthetase in cultured astrocytes.Brain Res. 2009 Nov 10;1297:1-8. doi: 10.1016/j.brainres.2009.08.070. Epub 2009 Aug 31. Brain Res. 2009. PMID: 19728998
-
Ca(2+)-dependent reduction of glutamate aspartate transporter GLAST expression in astrocytes by P2X(7) receptor-mediated phosphoinositide 3-kinase signaling.J Neurochem. 2010 Apr;113(1):213-27. doi: 10.1111/j.1471-4159.2010.06589.x. Epub 2010 Jan 13. J Neurochem. 2010. PMID: 20070863
-
Positive allosteric modulators of the metabotropic glutamate receptor subtype 2 (mGluR2).Curr Top Med Chem. 2005;5(9):869-84. doi: 10.2174/1568026054750281. Curr Top Med Chem. 2005. PMID: 16178732 Review.
-
Glutamate, glutamate receptors, and downstream signaling pathways.Int J Biol Sci. 2013 Sep 22;9(9):948-59. doi: 10.7150/ijbs.6426. eCollection 2013. Int J Biol Sci. 2013. PMID: 24155668 Free PMC article. Review.
Cited by
-
Roles of Glutamate Receptors in Parkinson's Disease.Int J Mol Sci. 2019 Sep 6;20(18):4391. doi: 10.3390/ijms20184391. Int J Mol Sci. 2019. PMID: 31500132 Free PMC article. Review.
-
Specific activation of mGlu2 induced IGF-1R transactivation in vitro through FAK phosphorylation.Acta Pharmacol Sin. 2019 Apr;40(4):460-467. doi: 10.1038/s41401-018-0033-7. Epub 2018 Jun 26. Acta Pharmacol Sin. 2019. PMID: 29946167 Free PMC article.
-
The Role of Neuroglial Metabotropic Glutamate Receptors in Alzheimer's Disease.Curr Neuropharmacol. 2023;21(2):273-283. doi: 10.2174/1570159X19666210916102638. Curr Neuropharmacol. 2023. PMID: 34530715 Free PMC article. Review.
-
Transcriptional Regulation of Glutamate Transporters: From Extracellular Signals to Transcription Factors.Adv Pharmacol. 2016;76:103-45. doi: 10.1016/bs.apha.2016.01.004. Epub 2016 Mar 24. Adv Pharmacol. 2016. PMID: 27288076 Free PMC article. Review.
-
Metabotropic glutamate 2,3 receptor stimulation desensitizes agonist activation of G-protein signaling and alters transcription regulators in mesocorticolimbic brain regions.Synapse. 2021 Apr;75(4):e22190. doi: 10.1002/syn.22190. Epub 2020 Oct 23. Synapse. 2021. PMID: 33025628 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous